Editorial [Hot Topic: ErbB Family and Downstream Signal Transduction Pathways as Targets for Anticancer Therapy (Guest Editor: F. Caponigro)]
Journal:
Current Drug Targets
Volume:
6
Page:
241-242
Author(s):
F. Caponigro
Small Molecules with EGFR-TK Inhibitor Activity
Journal:
Current Drug Targets
Volume:
6
Page:
259-274
Author(s):
Joan Albanell and Pere Gascon
Isoprenylation of Intracellular Proteins as a New Target for the Therapy of Human Neoplasms: Preclinical and Clinical Implications
Journal:
Current Drug Targets
Volume:
6
Page:
301-323
Author(s):
M. Caraglia, A. Budillon, P. Tagliaferri, M. Marra, A. Abbruzzese and F. Caponigro
Drugging Cell Cycle Kinases in Cancer Therapy
Journal:
Current Drug Targets
Volume:
6
Page:
325-335
Author(s):
S. Blagden and J. de Bono
Multiple-Target Drugs: Inhibitors of Heat Shock Protein 90 and of Histone Deacetylase
Journal:
Current Drug Targets
Volume:
6
Page:
337-351
Author(s):
A. Budillon, F. Bruzzese, E. Di Gennaro and M. Caraglia
Novel Subtype Specific and Universal Somatostatin Analogues: Clinical Potential and Pitfalls
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1573-1592
Author(s):
Joost van der Hoek, Leo J. Hofland and Steven W.J. Lamberts
Recent Developments in the Chemical Biology of Epothilones
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1595-1613
Author(s):
Karl Heinz Altmann
The Epigenomic Viewpoint on Cellular Differentiation of Myeloid Progenitor Cells as it Pertains to Leukemogenesis
Journal:
Current Genomics
Volume:
6
Page:
137-143
Author(s):
Vincent E. Sollars
Therapeutic Antibodies
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
2
Page:
209-217
Author(s):
J. R. Adair and A. D. G. Lawson
Prospects for Plant-Derived Chemopreventive Agents Exhibiting Multiple Mechanisms of Action
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
201-213
Author(s):
L. M. Howells and M. M. Manson